Ezetimibe
NDC 10135-787, Ezetimibe, tablet, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-787
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215693
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-787 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EZETIMIBE10 mg/1
Pharmacologic classes
Decreased Cholesterol Absorption [PE]; Dietary Cholesterol Absorption Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-787-05 | 10135078705 | 500 TABLET in 1 BOTTLE (10135-787-05) |
| 10135-787-30 | 10135078730 | 30 TABLET in 1 BOTTLE (10135-787-30) |
| 10135-787-90 | 10135078790 | 90 TABLET in 1 BOTTLE (10135-787-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/109a22f4-a7cb-96c6-e063-6394a90ad7f6
Use it
Look up 10135-787 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-787 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-787. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.